# OnCo record paper-donadieu-vemurafenib-refractory-multisystem-lch-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-donadieu-vemurafenib-refractory-multisystem-lch-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-donadieu-vemurafenib-refractory-multisystem-lch-jco-2019" ;
  schema:name "Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study"@en ;
  schema:description "In children with life-threatening Langerhans cell histiocytosis that had not responded to chemotherapy, the BRAF inhibitor vemurafenib brought the disease under control in nearly all of them, though it usually returned when the drug was stopped."@en ;
  schema:url <https://onco.cc/key-papers/paper-donadieu-vemurafenib-refractory-multisystem-lch-jco-2019/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00456>, <https://pubmed.ncbi.nlm.nih.gov/31513482/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.00456> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Donadieu J, Larabi IA, Tardieu M, et al." ;
  onco:cancers <https://onco.cc/cancers/lch-multisystem/> ;
  onco:drugs <https://onco.cc/drugs/vemurafenib/> ;
  onco:journals <https://onco.cc/journals/jco/> .
